Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

trabectedin

(truh-BEK-teh-din)
A drug used to treat liposarcoma and leiomyosarcoma (types of soft tissue sarcoma) that cannot be removed by surgery or have spread to other parts of the body. It is used in patients who have already been treated with other anticancer drugs. It is also being studied in the treatment of other types of cancer. Trabectedin may kill cancer cells by damaging their DNA and stopping them from dividing. It is a type of alkylating agent. Also called ecteinascidin, ET 743, and Yondelis.
More Information
Search NCI's Dictionary of Cancer Terms